Insempra is a biotechnology-powered company enabling businesses to transform their ingredient lists with superior bio-based products.
Insempra has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in May 2024.
Insempra's investors include EQT Ventures, BlueYard Capital, Acequia Capital (AceCap), Alante Capital, Bayern Kapital.
Insempra is headquartered in Planegg, Germany.
Insempra is a biotechnology-powered company enabling businesses to transform their ingredient lists with superior bio-based products.
Insempra is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Insempra — Funding & Investors." VCBacked, May 7, 2024, https://www.vcbacked.co/company/insempra. Accessed October 30, 2026.
VCBacked. (2024). Insempra — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/insempra
{{cite web |title=Insempra — Funding & Investors |url=https://www.vcbacked.co/company/insempra |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated